Gamma-glutamyltransferase, cardiovascular disease and mortality in individuals with diabetes mellitus

Diabetes/Metabolism Research and Reviews

Volumn 28, Issue 3, 2012, Pages 284-288

  Sluik, Diewertje ^a   Beulens, Joline W J ^b   Weikert, Cornelia ^a,c   Van Dieren, Susan ^b   Spijkerman, Annemieke M W ^d   Van der A, Daphne L ^d   Fritsche, Andreas ^e   Joost, Hans Georg ^a   Boeing, Heiner ^a   Nöthlings, Ute ^a,f  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f UNIVERSITY OF KIEL   (Germany)

Author keywords

Cardiovascular diseases; Diabetes mellitus; Gamma glutamyltransferase; Mortality; Myocardial infarction; Stroke

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; ENZYME ACTIVITY; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING;

AGED; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; GERMANY; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; RISK FACTORS; SMOKING; WAIST CIRCUMFERENCE;

EID: 84858126545     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2261     Document Type: Article

References (20)

1. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001; 38(4): 263-355.
2. Targher G. Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer - a narrative review. Clin Chem Lab Med 2010; 48(2): 147-157.
3. Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Ther 2008; 88(11): 1254-1264.
4. Seshasai SR, Kaptoge S, Thompson A, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011; 364(9): 829-841. DOI: 10.1056/NEJMoa1008862.
5. Wannamethee G, Ebrahim S, Shaper AG. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 1995; 142(7): 699-708.
6. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002; 5(6B): 1113-1124.
7. Boeing H, Korfmann A, Bergmann MM. Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition. Ann Nutr Metab 1999; 43(4): 205-215.
8. Beulens JW, Monninkhof EM, Verschuren WM, et al. Cohort profile: the EPIC-NL study. Int J Epidemiol 2010; 39(5): 1170-1178.
9. van Dieren S, Nothlings U, van der Schouw YT, et al. Non-fasting lipids and risk of cardiovascular disease in patients with diabetes mellitus. Diabetologia 2011; 54(1): 73-77. DOI: 10.1007/s00125-010-1945z.
10. van Dieren S, Peelen LM, Nothlings U, et al. External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes. Diabetologia 2011; 54(2): 264-270. DOI: 10.1007/s00125-010-1660-0.
11. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163, 944 Austrian adults. Circulation 2005; 112(14): 2130-2137.
12. Emdin M, Pompella A, Paolicchi A. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation 2005; 112(14): 2078-2080.
13. Lee DH, Buijsse B, Steffen L, Holtzman J, Luepker R, Jacobs DR Jr. Association between serum gamma-glutamyltransferase and cardiovascular mortality varies by age: the Minnesota Heart Survey. Eur J Cardiovasc Prev Rehabil 2009; 16(1): 16-20.
14. Sluik D, Boeing H, Montonen J, et al. Associations between general and abdominal adiposity and mortality in individuals with diabetes mellitus. Am J Epidemiol 2011; 174(1): 22-34. DOI: 10.1093/aje/kwr048.
15. Drogan D, Weikert C, Dierkes J, et al. Plasma gamma-glutamyltransferase, cysteinyl-glycine, and oxidized low-density lipoprotein: a pathway associated with myocardial infarction risk? Arterioscler Thromb Vasc Biol 2010; 30(10): 2053-2058. DOI: 10.1161/ATVBAMA.110.209346.
16. Monami M, Balzi D, Lamanna C, et al. Prognostic value of serum liver enzymes levels in type 2 diabetic patients. Diabetes Metab Res Rev 2007; 23: 625-630. DOI: 10.1002/dmrr.744.
17. Bots ML, Salonen JT, Elwood PC, et al. Gamma-glutamyltransferase and risk of stroke: the EUROSTROKE project. J Epidemiol Community Health 2002; 56(Suppl 1): i25-i29.
18. Lee DH, Silventoinen K, Hu G, et al. Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28, 838 middle-aged men and women. Eur Heart J 2006; 27(18): 2170-2176.
19. Smith BW, Adams LA. Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. Nat Rev Endocrinol 2011; 7(8): 456-465. DOI: 10.1038/nrendo.2011.72.
20. Berry C, Tardif JC, Bourassa MG. Coronary heart disease in patients with diabetes: part I: recent advances in prevention and noninvasive management. J Am Coll Cardiol 2007; 49(6): 631-642.